Advanced Hemodynamic Monitoring Beyond Cardiac Output: Venous Excess Ultrasound (VExUS) and Microcirculation Assessment in Critical Care

Dr Neeraj Manikath , claude.ai

Abstract

Traditional hemodynamic monitoring has predominantly focused on cardiac output optimization and arterial pressure management. However, emerging evidence suggests that venous congestion and microcirculatory dysfunction are critical determinants of organ failure and patient outcomes in critically ill patients. This review explores advanced hemodynamic monitoring techniques beyond conventional cardiac output measurements, specifically focusing on Venous Excess Ultrasound (VExUS) scoring and microcirculation monitoring. We discuss the physiological rationale, clinical applications, and implementation strategies for these novel approaches in intensive care units. The integration of these monitoring modalities offers a more comprehensive understanding of circulatory physiology and may guide more precise therapeutic interventions in critical illness.

Keywords: VExUS, microcirculation, hemodynamic monitoring, venous congestion, critical care, ultrasound

Introduction

The paradigm of hemodynamic monitoring in critical care has traditionally centered on optimizing cardiac output, maintaining adequate mean arterial pressure, and ensuring oxygen delivery to tissues. While these parameters remain fundamental, they provide an incomplete picture of circulatory physiology. The Frank-Starling mechanism, which has guided fluid resuscitation strategies for decades, assumes that increased venous return translates to improved cardiac performance. However, this relationship becomes complex in critically ill patients where venous congestion may paradoxically worsen organ function despite adequate cardiac output.

Recent advances in point-of-care ultrasound and microcirculation assessment have revealed the critical importance of venous physiology and tissue-level perfusion in determining patient outcomes. Venous Excess Ultrasound (VExUS) scoring and sublingual microcirculation monitoring represent paradigm shifts toward understanding the "back-end" of circulation and the ultimate destination of oxygen delivery—the microcirculation.

Venous Excess Ultrasound (VExUS): Beyond the Traditional Preload Assessment

Physiological Foundation

Venous congestion represents a state where elevated venous pressures impair organ perfusion through multiple mechanisms:

Venous-Arterial Coupling Dysfunction: Elevated venous pressures reduce the arteriovenous pressure gradient, compromising perfusion pressure at the tissue level.
Organ Compartment Syndrome: In encapsulated organs like the kidneys and liver, venous congestion increases interstitial pressure, reducing capillary perfusion pressure.
Lymphatic Dysfunction: Elevated venous pressures impair lymphatic drainage, leading to tissue edema and further compromising microcirculatory function.

VExUS Scoring System: Technical Approach

The VExUS score integrates ultrasound assessment of inferior vena cava (IVC) diameter with Doppler evaluation of hepatic, portal, and intrarenal venous flow patterns. This multimodal approach provides a comprehensive assessment of systemic venous congestion.

🔍 Clinical Pearl: The VExUS score moves beyond simple IVC diameter measurements by incorporating flow patterns that reflect downstream organ congestion, making it a more physiologically relevant assessment tool.

Component 1: IVC Assessment

Severe (3 points): IVC diameter >2 cm with <50% respiratory variation
Moderate (2 points): IVC diameter >2 cm with ≥50% respiratory variation
Mild (1 point): IVC diameter ≤2 cm with <50% respiratory variation
Normal (0 points): IVC diameter ≤2 cm with ≥50% respiratory variation

Component 2: Hepatic Vein Doppler

Severe (3 points): Pulsatile flow with systolic flow reversal
Moderate (2 points): Pulsatile flow without systolic flow reversal
Mild (1 point): Flat, non-pulsatile flow
Normal (0 points): Normal triphasic waveform

Component 3: Portal Vein Assessment

Severe (2 points): Pulsatile flow (pulsatility fraction >30%)
Mild (1 point): Flat flow with minimal respiratory variation
Normal (0 points): Normal continuous flow with respiratory variation

Component 4: Intrarenal Venous Flow

Severe (2 points): Discontinuous flow pattern
Mild (1 point): Continuous monophasic flow
Normal (0 points): Normal continuous biphasic flow

🎯 Clinical Hack: The "Rule of 3s" - Severe VExUS (≥3 points) correlates with clinically significant venous congestion requiring intervention, while mild VExUS (1-2 points) suggests subclinical congestion that may benefit from careful monitoring.

Clinical Applications and Outcomes

Multiple studies have demonstrated the prognostic value of VExUS scoring:

Acute Kidney Injury (AKI) Prediction: Beaubien-Souligny et al. demonstrated that severe VExUS scores predicted AKI development with superior accuracy compared to traditional preload markers (AUC 0.77 vs 0.51 for CVP). The physiological explanation lies in the kidney's unique vulnerability to venous congestion due to its encapsulated nature and dependence on adequate perfusion pressure.

Fluid Responsiveness Assessment: Unlike traditional preload assessments that focus on the heart's ability to increase stroke volume, VExUS evaluates whether additional fluid will worsen organ congestion. Patients with severe VExUS scores rarely benefit from fluid administration regardless of cardiac output response.

Weaning from Mechanical Ventilation: Venous congestion can impair diaphragmatic function and increase work of breathing. VExUS scoring helps identify patients who may benefit from decongestion strategies before ventilator weaning attempts.

🍎 Teaching Pearl: Think of VExUS as the "traffic report" for your patient's venous system—it tells you where the congestion is and how severe the backup has become.

Microcirculation Monitoring: Where Oxygen Delivery Meets Tissue Demand

The Microcirculatory Paradigm

The microcirculation represents the ultimate destination of cardiovascular therapy, where oxygen and nutrients are delivered to tissues. Despite adequate cardiac output and systemic blood pressure, microcirculatory dysfunction can lead to tissue hypoxia and organ failure. This phenomenon, termed "microcirculatory shunting" or "cytopathic hypoxia," highlights the limitations of macro-hemodynamic monitoring.

Sublingual Microcirculation Assessment

Technical Methodology

Sublingual microcirculation assessment utilizes handheld vital microscopy devices (such as sidestream dark-field imaging or incident dark-field imaging) to visualize small vessels (<20 μm diameter) in the sublingual mucosa. This site serves as an accessible window to systemic microcirculatory function due to its:

Similar embryological origin to splanchnic circulation
Accessibility without invasive procedures
Rapid response to systemic interventions
Minimal artifact from movement or external pressure

Key Parameters for Assessment

Microvascular Flow Index (MFI):

0: No flow
1: Intermittent flow
2: Sluggish flow
3: Normal continuous flow

Perfused Vessel Density (PVD): Number of perfused vessels per unit area (vessels/mm²)

Proportion of Perfused Vessels (PPV): Percentage of vessels with continuous flow

Total Vessel Density (TVD): Total number of vessels per unit area, regardless of flow

⚡ Clinical Hack: The "3-3-3 Rule" for normal microcirculation: MFI >2.6, PPV >75%, and PVD >15 vessels/mm² generally indicate adequate microcirculatory function.

Pathophysiological Patterns in Critical Illness

Septic Shock

Early Phase: Increased vessel density with heterogeneous flow patterns
Late Phase: Decreased vessel density with sluggish or absent flow
Recovery: Gradual normalization of flow patterns often preceding macro-hemodynamic improvement

Cardiogenic Shock

Primary Pattern: Decreased vessel density with sluggish flow
Response to Therapy: Improvement in flow velocity often precedes cardiac output recovery

Hemorrhagic Shock

Compensatory Phase: Maintained vessel density with increased flow velocity
Decompensated Phase: Rapid deterioration in all microcirculatory parameters

🔬 Research Pearl: Microcirculatory dysfunction often persists despite normalization of macro-hemodynamic parameters, explaining why some patients develop multiple organ failure despite adequate cardiac output and blood pressure.

Integration into Clinical Practice: The Comprehensive Hemodynamic Assessment

The Modern Hemodynamic Monitoring Pyramid

Foundation: Traditional monitoring (cardiac output, blood pressure, CVP)
Structural Assessment: Echocardiography for cardiac function and loading conditions
Venous Assessment: VExUS scoring for congestion evaluation
Microcirculatory Assessment: Sublingual microcirculation monitoring
Tissue Markers: Lactate, ScvO2, and organ-specific biomarkers

Clinical Decision-Making Algorithm

Scenario 1: Adequate Cardiac Output with Organ Dysfunction

Traditional Approach: Increase inotropes or vasopressors
Advanced Approach: Assess VExUS and microcirculation
- If severe VExUS: Consider decongestion therapy
- If microcirculatory dysfunction: Optimize perfusion pressure and consider microcirculatory-targeted therapy

Scenario 2: Low Cardiac Output with Normal Blood Pressure

Traditional Approach: Fluid challenge
Advanced Approach:
- Assess VExUS first
- If severe VExUS: Avoid fluids, consider inotropes
- If normal VExUS: Proceed with fluid challenge while monitoring microcirculation

🎪 Clinical Oyster: A patient with septic shock may have normal cardiac output and adequate blood pressure but severe microcirculatory dysfunction. Traditional monitoring would suggest adequate resuscitation, but microcirculation assessment reveals ongoing tissue hypoperfusion requiring targeted therapy.

Therapeutic Implications and Interventions

VExUS-Guided Decongestion Strategies

Diuretic Optimization:

Loop diuretics remain first-line for volume removal
Consider combination therapy (loop + thiazide) for severe congestion
Monitor VExUS response rather than just weight or fluid balance

Ultrafiltration:

Consider for patients with severe VExUS and diuretic resistance
Allows precise volume control without electrolyte disturbances
Particularly useful in patients with concurrent AKI

Venodilator Therapy:

Nitroglycerin can reduce venous tone and improve VExUS scores
Particularly useful in patients with heart failure and venous congestion
Monitor for hypotension and adjust vasopressor support accordingly

🔧 Practical Hack: Start with low-dose diuretics and serial VExUS assessments rather than aggressive diuresis, as small volume changes can significantly improve venous congestion.

Microcirculation-Targeted Therapies

Vasopressor Selection:

Norepinephrine generally preserves microcirculatory function better than high-dose dopamine
Consider vasopressin in distributive shock to improve microvascular tone

Perfusion Pressure Optimization:

Target MAP based on microcirculatory response rather than arbitrary thresholds
Some patients may require higher MAP (75-85 mmHg) for adequate microcirculation

Anti-inflammatory Strategies:

Early appropriate antibiotics in sepsis improve microcirculatory function
Consider adjunctive therapies (vitamin C, thiamine, hydrocortisone) in refractory cases

Technical Considerations and Limitations

VExUS Implementation Challenges

Learning Curve: Requires specific ultrasound skills and pattern recognition Patient Factors: Mechanical ventilation, obesity, and bowel gas can affect image quality Operator Dependence: Significant inter-observer variability in early implementation phases Standardization: Need for consistent protocols and training programs

🎓 Teaching Strategy: Establish a structured training program with:

Didactic sessions on venous physiology
Hands-on workshops with simulator training
Supervised clinical assessments with experienced operators
Regular quality assurance reviews

Microcirculation Monitoring Limitations

Accessibility: Requires specialized equipment and trained personnel Temporal Variations: Microcirculatory parameters can fluctuate rapidly Site Specificity: Sublingual findings may not always reflect systemic microcirculation Lack of Standardization: Limited consensus on normal values and therapeutic targets

Future Directions and Research Opportunities

Artificial Intelligence Integration

Machine learning algorithms for automated VExUS scoring
Pattern recognition software for microcirculation assessment
Predictive models combining multiple monitoring modalities

Personalized Medicine Applications

Genetic markers affecting microcirculatory response
Precision dosing of vasoactive medications based on microcirculatory response
Individualized fluid management protocols

Novel Therapeutic Targets

Microcirculatory-specific interventions
Glycocalyx protection strategies
Endothelial function optimization

Clinical Pearls and Teaching Points

🌟 Master Pearl: "Traditional hemodynamic monitoring tells you about the highway system (macro-circulation), but VExUS and microcirculation monitoring tell you about the neighborhood streets and driveways where your patients actually live."

📚 Educational Hack for Trainees:

VExUS Mnemonic: "HPIR" - Hepatic, Portal, IVC, Renal veins
Microcirculation Mnemonic: "FPD" - Flow, Perfusion, Density

🎯 Clinical Decision Framework:

Start with traditional monitoring for stability
Add VExUS for congestion assessment
Include microcirculation for tissue-level evaluation
Integrate findings for comprehensive management

Conclusion

Advanced hemodynamic monitoring beyond cardiac output represents a fundamental evolution in critical care practice. VExUS scoring provides crucial insights into venous physiology and organ congestion, while microcirculation monitoring reveals tissue-level perfusion adequacy. These tools complement rather than replace traditional monitoring, offering a more comprehensive understanding of circulatory physiology.

The integration of these advanced monitoring techniques requires dedicated training, standardized protocols, and a shift in clinical thinking from macro-hemodynamic optimization to comprehensive circulatory assessment. As we move toward precision medicine in critical care, these tools will become increasingly important for individualizing therapy and improving patient outcomes.

The future of hemodynamic monitoring lies not in replacing traditional approaches but in creating a multi-layered assessment strategy that spans from macro-circulation to microcirculation, providing clinicians with unprecedented insights into the complex physiology of critical illness.

References

Beaubien-Souligny W, Rola P, Haycock K, et al. Quantifying systemic congestion with Point-Of-Care ultrasound: development of the venous excess ultrasound grading system. Ultrasound J. 2020;12(1):16.
Rola P, Miralles-Aguiar F, Argaiz E, et al. Clinical applications of the venous excess ultrasound (VExUS) score: conceptual review and case series. Ultrasound J. 2021;13(1):32.
Ince C, Boerma EC, Cecconi M, et al. Second consensus on the assessment of sublingual microcirculation in critically ill patients: results from a task force of the European Society of Intensive Care Medicine. Intensive Care Med. 2018;44(3):281-299.
De Backer D, Creteur J, Preiser JC, Dubois MJ, Vincent JL. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med. 2002;166(1):98-104.
Sakr Y, Dubois MJ, De Backer D, Creteur J, Vincent JL. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med. 2004;32(9):1825-31.
Top AP, Ince C, de Meij N, van Dijk M, Tibboel D. Persistent low microcirculatory vessel density in nonsurvivors of sepsis in pediatric intensive care. Crit Care Med. 2011;39(1):8-13.
Hernandez G, Ospina-Tascon G, Damiani LP, et al. Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: the ANDROMEDA-SHOCK randomized clinical trial. JAMA. 2019;321(7):654-664.
Longino A, Martin K, Leyba K, et al. Correlation between the VExUS score and right atrial pressure: a pilot prospective observational study. Crit Care. 2023;27(1):205.
Guinot PG, Laurencet M, Berthoud V, et al. VExUS score predicts post-operative acute kidney injury and hospital length-of-stay in cardiac surgery patients. J Clin Med. 2022;11(15):4297.
Bowcock E, Cowburn P, Orde S. VExUS for heart failure: a new gold standard for decongestive therapy. JACC Heart Fail. 2022;10(12):967-969.

Tuesday, September 23, 2025